Boston Scientific raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...

Medtronic has launched the Avalus Ultra Bioprosthesis valve, its next-generation surgical aortic heart valve, in India.

Smithsonian biologists are using heart monitors designed for humans to study how high stress levels in animals can hinder ...

Athens, Tenn.-based Starr Regional Medical Center completed its first implantation of Medtronic’s Micra leadless pacemaker, a device for patients with slow heart rhythms.  The minimally invasive ...

Boston Scientific has lifted its fiscal year 2025 (FY25) profit outlook to between $3.02 and $3.04 per share amid continued ...

Medtronic is no stranger to breakthroughs like this, and the company's innovations, which often help push standards of care forward, do grant it pricing power, as healthcare systems are willing to pay ...

Medtronic’s stock sat on the discount rack for years. Then, in August, a well-known activist investor finally took the bait, ...

Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s ...